In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy
Open Access
- 18 November 2021
- journal article
- letter
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 16 (1) , 1-4
Abstract
Background: ABCB11 variations are responsible for a spectrum of rare liver diseases, including progressive familial intrahepatic cholestasis type 2 (PFIC2) and intrahepatic cholestasis of pregnancy (ICP). Current medical treatment of these conditions mostly relies on ursodeoxycholic acid with limited efficacy. We report on the in vitro study of the p.A257V missense variant of ABCB11 identified in a PFIC2 patient and in her mother who experienced ICP. Results: The Ala257 residue is located outside the ATP-binding site of ABCB11. We show that the p.A257V variant of ABCB11 is correctly expressed at the canalicular membrane of HepG2 cells but that its function significantly decreased when studied in MDCK cells. This functional defect can be fully rescued by Ivacaftor. Conclusion: Ivacaftor could be considered as a new pharmacological tool able to respond to an unmet medical need for patients with ICP and PFIC2 due to ABCB11 variations affecting ABCB11 function, even when the residue involved is not located in an ATP-binding site of ABCB11.Keywords
Funding Information
- Ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation
This publication has 12 references indexed in Scilit:
- Cryo-EM structure of human bile salts exporter ABCB11Cell Research, 2020
- Two Unanticipated Pregnancies While on Cystic Fibrosis Gene-Specific Drug TherapyJournal of Patient Experience, 2019
- Cystic fibrosis drug ivacaftor stimulates CFTR channels at picomolar concentrationseLife, 2019
- Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformationScience, 2018
- The pathophysiology of intrahepatic cholestasis of pregnancyClinics and Research in Hepatology and Gastroenterology, 2016
- Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4‐phenylbutyrateHepatology, 2015
- Transcriptional dynamics of bile salt export pump during pregnancy: Mechanisms and implications in intrahepatic cholestasis of pregnancyHepatology, 2014
- Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homologProceedings of the National Academy of Sciences, 2014
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent MannerJournal of Biological Chemistry, 2012
- Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancyThe Lancet, 1999